"Longevity" gets marketed as a destination, but in research it's a framework. In 2013 a landmark paper proposed the "hallmarks of aging" — a shared map of the cellular processes that go wrong over time — and it has organised the field ever since (and been expanded with newer hallmarks).
The core hallmarks
- Genomic instability — accumulating DNA damage outpacing repair.
- Telomere attrition — the protective caps on chromosomes shortening with each division.
- Epigenetic alterations — drift in how genes are switched on and off.
- Loss of proteostasis — the cell's protein quality-control machinery faltering.
- Cellular senescence — cells that stop dividing but won't die.
- Mitochondrial dysfunction — the cell's power plants becoming less efficient.
Why senescence gets so much attention
Senescent cells — sometimes nicknamed "zombie cells" — accumulate with age and secrete a cocktail of inflammatory molecules (the SASP) that damages surrounding healthy tissue. Clearing them in animal models has produced striking healthspan improvements, which is why "senolytics" are one of the hottest areas in the field.
The honest status
Most pharmacological interventions targeting these hallmarks are preclinical or early-stage. The interventions with the strongest human evidence remain unglamorous: regular exercise, sleep, not smoking, and dietary patterns that support metabolic health — each of which touches several hallmarks at once.
The map is excellent; we're still learning to drive on it.
For research and educational purposes only. Not medical advice.